{"id":520291,"date":"2021-07-29T16:10:43","date_gmt":"2021-07-29T20:10:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/"},"modified":"2021-07-29T16:10:43","modified_gmt":"2021-07-29T20:10:43","slug":"cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/","title":{"rendered":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MINNEAPOLIS, July  29, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rEnO_CexCaDOLe2WJtsE582bHawg-hbwISrPtFCwC1dkOIQrAG0UpOdblcDKHpfP\" rel=\"nofollow noopener\" target=\"_blank\">CVRx<\/a>, Inc. (\u201cCVRx\u201d), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced that\u00a0the management team will participate in the Canaccord Genuity 41<sup>st<\/sup> Annual Growth Conference on\u00a0Thursday, August 12, 2021. The Company is scheduled to present at the conference at\u00a011:00 am Eastern Time\u00a0the same day via webcast.<\/p>\n<p>A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d5C0C-Cc7Cuy_FUr7p-t-zUilYKd_4CS5ZNk0WzRM7qC1gpXICzCp6-qcpFIh87i5PX-hk7RouR7X2-G7MiOGQ==\" rel=\"nofollow noopener\" target=\"_blank\">ir.cvrx.com<\/a>. A replay of the webcast will be archived on the website for approximately 90 days.<\/p>\n<p><strong>About CVRx, Inc.<\/strong><br \/>CVRx is focused on the development and commercialization of Barostim\u2122, the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate the body\u2019s baroreflex, which in turn triggers an autonomic response to the heart. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the US. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uSRbpRy6y1rO7kcWpIset81xx567l8IOhGXuvTYiHeR7xKM-6AYlsvBHve1t2__9qfLZ5SqJTQBKft5xffbIIw==\" rel=\"nofollow noopener\" target=\"_blank\">www.cvrx.com<\/a>.<\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Mark Klausner or Mike Vallie<br \/>Westwicke, an ICR Company<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bNHLqw4h-GNgzNPsdbxe_uYCTe3drV2r_YGgGbk9BI9N1V2Bl5DXmorAuRKNLNGISKeuM61lkNV1cRuuTIihQA==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>ir@cvrx.com<\/strong><\/a><\/p>\n<p><strong>Media Contact:<\/strong><br \/>Lisa Murray<br \/>Trevi Communications, Inc.<br \/>978.750.0333 \/ 617.835.0396<br \/><strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A5-4PKq9yjKj5QrOc77YzdIkWYuFtYj-LyhuviXInFreXVmCaFgLgL-7E81pYHiLHVU_8PPL5DBjKP1Pw1FYe479IDRBJHjKkLyJz2BgpyM=\" rel=\"nofollow noopener\" target=\"_blank\">lisa@trevicomm.com<\/a><\/u><\/strong><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/3caee97a-d537-4f3f-b163-7e5f6c25b046\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) &#8212; CVRx, Inc. (\u201cCVRx\u201d), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced that\u00a0the management team will participate in the Canaccord Genuity 41st Annual Growth Conference on\u00a0Thursday, August 12, 2021. The Company is scheduled to present at the conference at\u00a011:00 am Eastern Time\u00a0the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at\u00a0ir.cvrx.com. A replay of the webcast will be archived on the website for approximately 90 days. About CVRx, Inc.CVRx is focused on the development and commercialization of Barostim\u2122, the first medical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-520291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) &#8212; CVRx, Inc. (\u201cCVRx\u201d), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced that\u00a0the management team will participate in the Canaccord Genuity 41st Annual Growth Conference on\u00a0Thursday, August 12, 2021. The Company is scheduled to present at the conference at\u00a011:00 am Eastern Time\u00a0the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at\u00a0ir.cvrx.com. A replay of the webcast will be archived on the website for approximately 90 days. About CVRx, Inc.CVRx is focused on the development and commercialization of Barostim\u2122, the first medical &hellip; Continue reading &quot;CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-29T20:10:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference\",\"datePublished\":\"2021-07-29T20:10:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/\",\"name\":\"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\",\"datePublished\":\"2021-07-29T20:10:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk","og_description":"MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) &#8212; CVRx, Inc. (\u201cCVRx\u201d), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced that\u00a0the management team will participate in the Canaccord Genuity 41st Annual Growth Conference on\u00a0Thursday, August 12, 2021. The Company is scheduled to present at the conference at\u00a011:00 am Eastern Time\u00a0the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at\u00a0ir.cvrx.com. A replay of the webcast will be archived on the website for approximately 90 days. About CVRx, Inc.CVRx is focused on the development and commercialization of Barostim\u2122, the first medical &hellip; Continue reading \"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-29T20:10:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference","datePublished":"2021-07-29T20:10:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/","name":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==","datePublished":"2021-07-29T20:10:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzkyNSM0MzE4MTA3IzUwMDA3NTc4MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cvrx-to-present-at-the-canaccord-genuity-41st-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=520291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=520291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=520291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=520291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}